Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Bioorg Chem ; 146: 107276, 2024 May.
Article in English | MEDLINE | ID: mdl-38479132

ABSTRACT

Since the thalidomide incident, research on chiral drugs has escalated immensely. Differences in drug configuration can lead to significant variations in therapeutic efficacy. Matrine, a natural product esteemed for its low toxicity and high water solubility, has garnered significant attention in research endeavors. Nonetheless, its precise target has proven elusive. In this study, we designed and synthesized a novel chiral matrine derivative. Their cytotoxicity against three types of tumor cells was assessed. Comparing the newly synthesized derivatives to the parent matrine, most compounds exhibited significantly enhanced inhibitory effects on cancer cells. Among them, Q12 exhibited the highest activity, with IC50 values of 8.31 µM against rat glioma cells C6, 6.3 µM against human liver cancer cells HepG2 and 7.14 µM against human gastric cancer cells HGC-27, meanwhile showing low toxicity. Based on IC50 values, we constructed a preliminary structure-activity relationship (SAR). Compound Q12 significantly suppressed the cloning and migration of HepG2 cells. Further mechanistic studies indicated that Q12 inhibited Topo I in HepG2 cells, leading to DNA damage, induction of G0/G1 cell cycle arrest and ultimately causing apoptosis. The molecular docking experiments provided a rational binding mode of Q12 with the Topo I-DNA complex. In vivo, experiments demonstrated that Q12 exhibited a higher tumor growth inhibition rate (TGI) compared to the positive control drug Lenvatinib, while maintaining good safety. In summary, it suggests that Topo I might be a potential target for matrine and Q12 represents a promising candidate for cancer treatment.


Subject(s)
Antineoplastic Agents , Matrines , Humans , Rats , Animals , Molecular Docking Simulation , Cell Proliferation , Drug Screening Assays, Antitumor , Antineoplastic Agents/chemistry , Structure-Activity Relationship , Apoptosis , Molecular Structure , Drug Design , Cell Line, Tumor
2.
Eur J Med Chem ; 270: 116348, 2024 Apr 15.
Article in English | MEDLINE | ID: mdl-38554475

ABSTRACT

TOPOI inhibitors have long been a focal point in the research and development of antitumor drugs. PARP-1 plays a crucial role in repairing DNA damage induced by TOPOI inhibitors. Thus, concurrent inhibition of TOPOI and PARP-1 has the potential to augment drug activity. Matrine, characterized by low toxicity and good water solubility, offers advantageous properties. In this investigation, a series of benzimidazole matrine derivatives were designed and synthesized using matrine as the lead compound with the aim of developing dual inhibitors targeting both TOPOI and PARP-1. Among these derivatives, Compound B6 exhibited potent inhibitory effects on PARP-1 and TOPOI, effectively suppressing cancer cell proliferation and migration. Mechanistic assessments revealed that B6 induced DNA damage in HGC-27 cells, leading to G0/G1 cell cycle arrest and significant apoptosis. Molecular docking experiments demonstrated that B6 can effectively enter the active pocket of target proteins, where it forms stable hydrogen bonds with amino acid residues. In vivo, experiments demonstrated that B6 exhibited antitumor activity comparable to that of the positive control drug. The tumor growth inhibition rates (TGIs) for irinotecan, B6 and matrine were 87.0%, 75.4% and 9.7%, respectively. Importantly, B6 demonstrated lower toxicity than the positive control drug. Our findings suggest that TOPOI and PARP-1 may represent potential targets for matrine and B6 emerges as a promising candidate for cancer therapy.


Subject(s)
Antineoplastic Agents , Neoplasms , Poly(ADP-ribose) Polymerase Inhibitors/pharmacology , Matrines , Molecular Docking Simulation , Cell Line, Tumor , Antineoplastic Agents/chemistry , Cell Proliferation , Apoptosis , Benzimidazoles/pharmacology
4.
Diabetol Metab Syndr ; 16(1): 45, 2024 Feb 15.
Article in English | MEDLINE | ID: mdl-38360685

ABSTRACT

AIM: Cannabinoid receptors are components of the endocannabinoid system that affect various physiological functions. We aim to investigate the effect of cannabinoid receptor modulation on kidney disease. METHODS: PubMed, Web of Science databases, and EMBASE were searched. Articles selection, data extraction and quality assessment were independently performed by two investigators. The SYRCLE's RoB tool was used to assess the risk of study bias, and pooled SMD using a random-effect model and 95% CIs were calculated. Subgroup analyses were conducted in preselected subgroups, and publication bias was evaluated. We compared the effects of CB1 and CB2 antagonists and/or knockout and agonists and/or genetic regulation on renal function, blood glucose levels, body weight, and pathological damage-related indicators in different models of chronic and acute kidney injury. RESULTS: The blockade or knockout of CB1 could significantly reduce blood urea nitrogen [SMD,- 1.67 (95% CI - 2.27 to - 1.07)], serum creatinine [SMD, - 1.88 (95% CI - 2.91 to - 0.85)], and albuminuria [SMD, - 1.60 (95% CI - 2.16 to - 1.04)] in renal dysfunction animals compared with the control group. The activation of CB2 group could significantly reduce serum creatinine [SMD, - 0.97 (95% CI - 1.83 to - 0.11)] and albuminuria [SMD, - 2.43 (95% CI - 4.63 to - 0.23)] in renal dysfunction animals compared with the control group. CONCLUSIONS: The results suggest that targeting cannabinoid receptors, particularly CB1 antagonists and CB2 agonists, can improve kidney function and reduce inflammatory responses, exerting a renal protective effect and maintaining therapeutic potential in various types of kidney disease.

7.
BMC Ophthalmol ; 23(1): 128, 2023 Mar 29.
Article in English | MEDLINE | ID: mdl-36991349

ABSTRACT

BACKGROUND: This study evaluated the vascular changes in the macular and peripapillary regions before and after silicone oil (SO) removal in patients with rhegmatogenous retinal detachment. METHODS: This single-center case series assessed patients who underwent SO removal at one hospital. Patients who underwent pars plana vitrectomy and perfluoropropane gas tamponade (PPV + C3F8) were selected as controls. Superficial vessel density (SVD) and superficial perfusion density (SPD) in the macular and peripapillary regions were assessed by optical coherence tomography angiography (OCTA). Best-corrected visual acuity (BCVA) was assessed using LogMAR. RESULTS: Fifty eyes were administered SO tamponade, 54 SO tamponade(SOT) contralateral eyes, 29 PPV + C3F8 eyes, and 27 PPV + C3F8 contralateral eyes were selected. SVD and SPD in the macular region were lower in eyes administered SO tamponade compared with SOT contralateral eyes (P < 0.01). Except for the central area, SVD and SPD in the other areas of the peripapillary region were reduced after SO tamponade without SO removal (P < 0.01). No significant differences were found in SVD and SPD between PPV + C3F8 contralateral and PPV + C3F8 eyes. After SO removal, macular SVD and SPD showed significant improvements compared with preoperative values, but no improvements in SVD and SPD were observed in the peripapillary region. BCVA (LogMAR) decreased post-operation and was negatively correlated with macular SVD and SPD. CONCLUSIONS: SVD and SPD are decreased during SO tamponade and increased in the macular region of eyes that underwent SO removal, suggesting a possible mechanism for reduced visual acuity during or after SO tamponade. TRIAL REGISTRATION: Registration date: 22/05/2019; Registration number, ChiCTR1900023322; Registration site, Chinese Clinical Trial Registry (ChiCTR).


Subject(s)
Macula Lutea , Retinal Detachment , Humans , Angiography , Retinal Detachment/surgery , Retrospective Studies , Silicone Oils , Tomography, Optical Coherence , Vitrectomy
8.
BMC Ophthalmol ; 22(1): 74, 2022 Feb 13.
Article in English | MEDLINE | ID: mdl-35151281

ABSTRACT

BACKGROUND: Formulas predicting intraocular lens power have not been compared in silicone oil-tamponaded eyes. The study aims to compare six intraocular lens power assessment formulas in silicone oil-tamponaded eyes. METHODS: This prospective study included patients with silicone oil-tamponaded eyes scheduled for silicone oil removal, phacoemulsification, and intraocular lens implantation at Chongqing Aier Eye Hospital (June 2019 to December 2019). Implanted intraocular lens power was used to predict postsurgical spherical equivalence using SRK/T, Holladay 1, Holladay 2, Haigis, Hoffer Q, and Barrett Universal II, and assess those formula's predictive accuracy with predictive error. RESULTS: The analysis included 47 eyes in 47 patients (28 and 19 eyes with normal and long axial length, respectively). Postoperative spherical equivalence at 6 months in normal and long axial length eyes was - 0.6 ± 0.96 and - 0.8 ± 1.52 D, respectively. Predictive error values for SRK/T, Holladay 1, Holladay 2, Haigis, and Hoffer Q and Barrett Universal II were - 0.18 ± 0.92, - 0.15 ± 0.88, - 0.06 ± 0.94, - 0.15 ± 0.87, and - 0.05 ± 0.90 D and - 0.06 ± 0.90, respectively, for normal axial length eyes and 0.15 ± 1.16, 0.46 ± 1.17, 0.28 ± 1.11, - 0.04 ± 1.12, 0.49 ± 1.09 D and 0.11 ± 0.99, respectively, for long axial length eyes. For normal axial length eyes, predicted outcomes were similar to actual outcomes for all formulas. For long axial length eyes, predicted outcomes differed significantly from measured postsurgical values for Holladay 1, Holladay 2, and Hoffer Q (P < 0.05) but not SRK/T or Haigis or Barrett Universal II . CONCLUSIONS: The formulas had comparable predictive accuracy in silicone oil-tamponaded eyes with normal axial length, but Haigis or SRK/T or Barrett Universal II may be preferable in long axial length eyes. TRIAL REGISTRATION: ChiCTR1900023215.


Subject(s)
Lenses, Intraocular , Phacoemulsification , Axial Length, Eye , Biometry , Humans , Lens Implantation, Intraocular , Optics and Photonics , Prospective Studies , Refraction, Ocular , Retrospective Studies , Silicone Oils
9.
Dis Markers ; 2022: 6085072, 2022.
Article in English | MEDLINE | ID: mdl-35096203

ABSTRACT

The metabolic dysregulation is a hallmark of cancers including KIRC, specifically caused by alterations in metabolic genes. Currently, a lack of consensus exists between metabolic signatures in the tumor microenvironment. Here, in this study, we observed the significant correlations of differentially expressed metabolic genes (DEmGs) between KIRC and the related normal samples. Briefly, we collected sets of metabolic genes through RNA-seq data of KIRC and normal tissues from TCGA, followed by the identification of KIRC-related DEmGs. Next, patients were classified into three clusters, and using WGCNA, we identified metabolic genes involved in the survival among different clusters. Furthermore, we investigated survival and clinical parameters along with immune infiltration in the clusters. At the same time, we constructed and validated a prediction model based on these DEmGs. These analyses revealed that the patients having high expression of DEmGs showed poor survival, while infiltration of less-immune cells was associated with the metastasis of KIRC. In the end, we identified NUDT1 as a hub gene as it showed significantly high expression in KIRC samples as well as associated with the survival and prognosis of the patients. Further analysis revealed the oncogenic role of NUDT1 in 786-O and ACHN cells. Thus, we conclude that NUDT1 could be a potential diagnostic and prognostic marker for KIRC.


Subject(s)
Carcinoma, Renal Cell , Kidney Neoplasms , Carcinoma, Renal Cell/pathology , Gene Expression Regulation, Neoplastic , Humans , Kidney/metabolism , Kidney Neoplasms/pathology , Tumor Microenvironment/genetics
10.
Cell Death Dis ; 12(3): 255, 2021 03 10.
Article in English | MEDLINE | ID: mdl-33692334

ABSTRACT

Diabetic nephropathy (DN) is a serious complication in type 1 and type 2 diabetes, and renal interstitial fibrosis plays a key role in DN progression. Here, we aimed to probe into the role and potential mechanism of miR-483-5p in DN-induced renal interstitial fibrosis. In this study, we corroborated that miR-483-5p expression was lessened in type 1 and type 2 diabetic mice kidney tissues and high glucose (HG)-stimulated tubular epithelial cells (TECs), and raised in the exosomes derived from renal tissues in type 1 and type 2 diabetic mice. miR-483-5p restrained the expressions of fibrosis-related genes in vitro and renal interstitial fibrosis in vivo. Mechanistically, miR-483-5p bound both TIMP2 and MAPK1, and TIMP2 and MAPK1 were bound up with the regulation of miR-483-5p on renal TECs under HG conditions. Importantly, HNRNPA1-mediated exosomal sorting transported cellular miR-483-5p out of TECs into the urine. Our results expounded that HNRNPA1-mediated exosomal sorting transported cellular miR-483-5p out of TECs into the urine, thus lessening the restraint of cellular miR-483-5p on MAPK1 and TIMP2 mRNAs, and ultimately boosting extracellular matrix deposition and the progression of DN-induced renal interstitial fibrosis.


Subject(s)
Diabetic Nephropathies/metabolism , Epithelial Cells/metabolism , Exosomes/metabolism , Heterogeneous Nuclear Ribonucleoprotein A1/metabolism , Kidney Tubules/metabolism , MicroRNAs/metabolism , Animals , Blood Glucose/metabolism , Cell Line , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Diabetic Nephropathies/etiology , Diabetic Nephropathies/genetics , Diabetic Nephropathies/pathology , Disease Progression , Epithelial Cells/pathology , Exosomes/genetics , Fibrosis , Gene Expression Regulation , Heterogeneous Nuclear Ribonucleoprotein A1/genetics , Heterogeneous Nuclear Ribonucleoprotein A1/urine , Humans , Kidney Tubules/pathology , Male , Mice, Inbred C57BL , MicroRNAs/genetics , Mitogen-Activated Protein Kinase 1/genetics , Mitogen-Activated Protein Kinase 1/metabolism , Protein Transport , Tissue Inhibitor of Metalloproteinase-2/genetics , Tissue Inhibitor of Metalloproteinase-2/metabolism
11.
Springerplus ; 5(1): 1177, 2016.
Article in English | MEDLINE | ID: mdl-27512636

ABSTRACT

Inspired by track-before-detection technology in radar, a novel time-frequency transform, namely polynomial chirping Fourier transform (PCFT), is exploited to extract components from noisy multicomponent signal. The PCFT combines advantages of Fourier transform and polynomial chirplet transform to accumulate component energy along a polynomial chirping curve in the time-frequency plane. The particle swarm optimization algorithm is employed to search optimal polynomial parameters with which the PCFT will achieve a most concentrated energy ridge in the time-frequency plane for the target component. The component can be well separated in the polynomial chirping Fourier domain with a narrow-band filter and then reconstructed by inverse PCFT. Furthermore, an iterative procedure, involving parameter estimation, PCFT, filtering and recovery, is introduced to extract components from a noisy multicomponent signal successively. The Simulations and experiments show that the proposed method has better performance in component extraction from noisy multicomponent signal as well as provides more time-frequency details about the analyzed signal than conventional methods.

12.
J Hazard Mater ; 158(2-3): 287-92, 2008 Oct 30.
Article in English | MEDLINE | ID: mdl-18359156

ABSTRACT

The compound Sr(10)Bi(6)O(24-y) doped with Ni was prepared by solid-state reaction method. The obtained powders were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), UV-vis diffuse reflectance spectra and X-ray photoemission spectra (XPS). The Ni-doped Sr(10)Bi(6)O(24-y) samples assume a cubic perovskite structure with space group Fm3m (225). Bi in Sr(10)Bi(6)O(24-y) exists in the valence state of Bi(II). Photocatalytic activities of the prepared samples were evaluated using acid red G as a model organic compound. The results show that doping with 0.5 wt.% Ni can significantly improve the photoactivity of the compound Sr(10)Bi(6)O(24-y).


Subject(s)
Nickel/chemistry , Photochemistry , Strontium/chemistry , Catalysis , Kinetics , Microscopy, Electron, Scanning , Temperature , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL
...